Oxford BioDynamics Plc (AIM:OBD)

London flag London · Delayed Price · Currency is GBP · Price in GBX
0.260
-0.010 (-3.70%)
At close: Feb 27, 2026
-53.98%
Market Cap 11.16M
Revenue (ttm) 1.10M
Net Income (ttm) -11.15M
Shares Out 4.29B
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 37,990,690
Average Volume 23,197,682
Open 0.270
Previous Close 0.270
Day's Range 0.250 - 0.280
52-Week Range 0.203 - 0.780
Beta -0.50
RSI 43.00
Earnings Date Feb 27, 2026

About Oxford BioDynamics

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screening, evaluation, validation and monitoring of 3D genomic biomarker. Its p... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2007
Employees 41
Stock Exchange London Stock Exchange AIM
Ticker Symbol OBD
Full Company Profile

Financial Performance

In fiscal year 2025, Oxford BioDynamics's revenue was 1.10 million, an increase of 72.17% compared to the previous year's 636,000. Losses were -11.15 million, -3.58% less than in 2024.

Financial Statements

News

There is no news available yet.